Skip to content

Local Potential Measurement In PFA: A Pilot Study

Unipolar Signal Local Potential Measurement in Pulsed Field Ablation: A Pilot Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06877156
Enrollment
9
Registered
2025-03-14
Start date
2025-07-28
Completion date
2025-07-30
Last updated
2025-12-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial Fibrillation (AF)

Brief summary

This is a pilot study to collect unipolar signal data during a pulsed field ablation study for the treatment of atrial fibrillation and to test the performance of an algorithm designed to measure the local potential of the unipolar signal in real time.

Interventions

None listed

Sponsors

CathVision ApS
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Subjects with paroxysmal or persistent atrial fibrillation (AF) undergoing first time PFA procedure indicated by investigator for the treatment of atrial fibrillation. Male or non-pregnant female aged ≥18 years. Able and willing to provide written informed consent prior to any clinical investigation related procedure

Exclusion criteria

* Pregnant or nursing subjects. * Current participation in another investigational drug or device study that interferes with this study. * Subjects who, in the opinion of the investigator, are not candidates for this study. * Patients who have had a prior ablation procedure * Presence of other anatomic or comorbid conditions, or other medical, social, or psychological conditions that, in the investigator's opinion, could limit the subject's ability to participate in the clinical investigation or to comply with follow-up requirements, or impact the scientific soundness of the clinical investigation results. * Life expectancy is less than 12 months, in the opinion of the investigator * Subjects who, in the opinion of the investigator, are considered part of any vulnerable population.

Design outcomes

Primary

MeasureTime frameDescription
PFAnalyzer outputFrom enrollment to hospital discharge typically 1 dayThe automated peak-to-peak voltage of the local signal potential output from the PFAnalyzer will be compared to manual measurement of both unipolar and bipolar signals.

Countries

Croatia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026